Gasdermin-D driven pyroptosis fuels oxidative stress in ulcerative colitis: Biochemical and physiological correlations
Abstract
Ulcerative colitis (UC) is a chronic inflammatory bowel disease, resulting from intricate interplay among immune dysregulation, epithelial barrier malfunction and oxidative stress. Recent evidence has identified pyroptosis, a lytic and inflammatory type of programmed cell death, which is mediated by g asdermin D (GSDMD), as an important driver of intestinal inflammation. Pyroptosis also results in the release of proinflammatory cytokines, such as IL-18, that can further activate neutrophils and increase oxidative damage. Nevertheless, there are few integrated clinical research studies on the simultaneous detection of pyroptosis and cyt o kine release and oxidative stress markers in UC. Thus the aim of our research is to determine the serum concentrations of GSDMD, IL-18, myeloperoxidase (MPO), malondialdehyde (MDA) and C-reactive protein (CRP) in UC patients compared with healthy controls and to investigate their relationships as well as explore the diagnostic value of these indices for UC. Methods : A case-control study was performed with 45 patients who were diagnosed with UC and 45 age-matched healthy controls. Serum levels of GSDMD, IL-18, MPO, and MDA were assayed by enzyme linked immunosorbent assay (ELISA), and C-reactive protein (CRP) was assessed with immunodetection methods. Statistical analysis comprised independent t-tests, correlation, receiver operating characteristic (ROC) curve and logistic regression. Results : The concentration of serum GSDMD, IL-18, MPO, MDA and CRP in UC patients we re all obviously higher than that in controls (all P < 0.05). IL-18 was positively correlated with CRP (r = 0.481, p = 0.001) and MDA (r = 0.389, p = 0.008). The ROC analysis showed excellent diagnostic power for GSDMD (AUC = 0.993), IL-18 (AUC = 0.995), and MDA (AUC = 0.992) in distinguishing UC patients from healthy controls. In regression analysis, GSDMD and IL-18 were independent predictors for UC status. Conclusions : Together, these results favor a pathogenic model of UC where GSDMD-mediated pyroptosis leads to IL-18 release and subsequent neutrophil activation and oxidative lipid damage. GSDMD, IL-18 and MDA show promise as alternative non-invasive diagnostic markers. These findings emphasize the importance of both pyroptosis and oxidative stress next to other biological mechanisms in their translation into clinical aspects of UC.References
Arnhold, J. (2004). Properties, functions, and secretion of human myeloperoxidase. Biochemistry, 69(1), 4–9.
Ayala, A., Muñoz, M. F., & Argüelles, S. (2014). Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxidative Medicine and Cellular Longevity, 2014, 360438.
Buldukoglu, O. C., Ocal, S., Akca, S., Atar, G. E., Kaya, B., Isik, M. D., Koca, O., Harmandar, F. A., Cekin, Y., & Cekin, A. H. (2025). A novel inflammatory biomarker in assessing disease activity in ulcerative colitis: gasdermin D. BMC Gastroenterology, 25(1), 418.
Bulek, K., Zhao, J., Liao, Y., Rana, N., Corridoni, D., Antanaviciute, A., Chen, X., Wang, H., Qian, W., Miller-Little, W. A., Swaidani, S., Tang, F., Willard, B. B., McCrae, K., Kang, Z., Dubyak, G. R., Cominelli, F., Simmons, A., Pizarro, T. T., & Li, X. (2020). Epithelial-derived gasdermin D mediates nonlytic IL-1β release during experimental colitis. Journal of Clinical Investigation, 130(8), 4218–4234.
Chen, P., Zhou, G., Lin, J., Li, L., Zeng, Z., Chen, M., & Zhang, S. (2020). Serum biomarkers for inflammatory bowel disease. Frontiers in Medicine, 7, 123.
Dinarello, C. A., Novick, D., Kim, S., & Kaplanski, G. (2013). Interleukin-18 and IL-18 binding protein. Frontiers in Immunology, 4, 289.
Gao, X., Wang, C., Shen, X.-T., Li, C.-Y., Li, Y.-C., Gao, H., Qian, J.-M., & Zhang, X.-L. (2023). Pyroptosis burden is associated with anti-TNF treatment outcome in inflammatory bowel disease: new insights from bioinformatics analysis. Scientific Reports, 13(1), 15821.
Kaplanski, G., Dinarello, C. A., & Bongrand, P. (2003). Interleukin-18 and interleukin-1beta: Two cytokine substrates for ICE (caspase-1). Journal of Clinical Immunology, 23(1), 1–11.
Kayagaki, N., Stowe, I. B., Lee, B. L., O’Rourke, K., Anderson, K., Warming, S., Cuellar, T., Haley, B., Roose-Girma, M., Phung, Q. T., Liu, P. S., Lill, J. R., Li, H., Wu, J., Kummerfeld, S., Zhang, J., Lee, W. P., Snipas, S. J., Salvesen, G. S., … Dixit, V. M. (2015). Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature, 526(7575), 666–671.
Krzystek-Korpacka, M., Kempiński, R., Bromke, M. A., & Neubauer, K. (2020). Oxidative stress markers in inflammatory bowel diseases: Systematic review. Diagnostics, 10(8), 601.
Liu, X., Zhang, Z., Ruan, J., Pan, Y., Magupalli, V. G., Wu, H., & Lieberman, J. (2021). Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature, 535(7610), 153–158.
Ma, Z. R., Li, Y., & Yang, J. (2023). Inhibition of GSDMD-mediated pyroptosis attenuates colitis (Trichinella spiralis model). Parasites and Vectors, 16(1), 280.
Magro, F., Doherty, G., Peyrin-Biroulet, L., Svrcek, M., Borralho, P., Walsh, A., Carneiro, F., Rosini, F., de Hertogh, G., Biedermann, L., Pouillon, L., Scharl, M., Tripathi, M., Danese, S., Villanacci, V., & Feakins, R. (2020). ECCO Position Paper: Harmonization of the Approach to Ulcerative Colitis Histopathology. Journal of Crohn’s and Colitis, 14(11), 1503–1511.
Parry, A., Smith, S., & Jones, P. (2022). Biomarker panels in IBD: Combining inflammation and oxidative stress markers improves diagnostic accuracy. Clinical and Translational Gastroenterology, 13(3), e00402.
Rathkey, J. K., Zhao, J., Liu, Z., Chen, Y., Yang, J., Kondolf, H. C., ... & Li, X. (2018). Chemical disruption of the pyroptotic pore-forming protein gasdermin D inhibits inflammatory cell death and sepsis. Science Immunology, 3(26), eaat2738.
Seven, A., Aslan, M., Incir, S., & Altıntaş, A. (2021). Evaluation of oxidative and nitrosative stress in patients with ulcerative colitis: A case-control study. Arab Journal of Gastroenterology, 22(2), 106–110.
Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., Zhuang, Y., Cai, T., Wang, F., & Shao, F. (2015). Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature, 526(7575), 660–665.
Singh, S., Ananthakrishnan, A. N., Nguyen, N. H., & Feuerstein, J. D. (2023). AGA clinical practice guideline on the role of biomarkers for management of Crohn's disease (and related biomarker guidance). Gastroenterology, 165(6), 1367–1399.
Zhou, B., Zhang, J. Y., Liu, X. S., Chen, H. Z., Ai, Y. L., Cheng, K., Sun, R. Y., Zhou, D., Han, J., & Wu, Q. (2018). Tom20 senses iron-activated ROS signaling to promote melanoma cell pyroptosis. Cell Research, 28(12), 1171–1185.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons «Attribution» 4.0 License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.


